Kuehne+Nagel has strengthened its healthcare logistics infrastructure in Germany with the opening of a new 3,505 sq m logistics centre at Frankfurt Airport, designed specifically for temperature-sensitive pharmaceutical and healthcare products.
Located in Cargo City South, the facility forms part of a Kuehne+Nagel-owned 13,000 sq m complex. Its direct access to the airport tarmac, combined with connections to the cargo handling areas, is designed to accelerate the transfer of sensitive shipments between aircraft and the logistics centre.
The new centre is HealthChain-certified and provides several temperature-controlled storage environments. Around 2,500 sq m is dedicated to controlled room temperature storage between +15°C and +25°C, while more than 500 sq m is available for cold chain products requiring temperatures between +2°C and +8°C.
The facility also features ultra-low temperature freezers for products that must be maintained at -70°C, alongside temperature-controlled staging areas and specialised handling facilities for pharmaceutical trucking operations.
The centre is GDP-compliant and becomes part of Kuehne+Nagel’s global network of more than 270 HealthChain-certified locations, reinforcing the company’s infrastructure for healthcare and pharmaceutical logistics.
Frankfurt becomes a growing healthcare logistics hub
The investment adds to a series of healthcare logistics developments by Kuehne+Nagel in Frankfurt. Earlier this year, the company added Frankfurt to its Inspire Boeing 747-8F freighter network, expanding the airport’s role within its airfreight operations.
Kuehne+Nagel also launched the Frankfurt-Atlanta Cool Corridor, specifically designed to support temperature-sensitive healthcare shipments between the two locations.
Together, these developments provide additional capacity and specialised infrastructure as pharmaceutical and healthcare products increasingly require tightly controlled conditions throughout their transport journey.
Martin Schaefer, SVP Air Logistics Germany at Kuehne+Nagel, said the latest investment expands the company’s specialised infrastructure at a time when the movement of temperature-sensitive medicines is growing worldwide.
The new Frankfurt facility therefore combines temperature-controlled storage, specialised pharmaceutical handling and direct airport connectivity within a single healthcare logistics operation.
